AYTU - Company ID 0001385818
The table below shows AYTU BIOPHARMA, INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $3.28M | -$1.94M | -$1.39M | -$5.13M | -$28.82M | -$25.96M |
| Capital expenditure | $29.00K | $228.00K | $329.00K | - | - | - |
| Investing cash flow | -$29.00K | -$2.56M | -$329.00K | -$117.00K | -$3.25M | -$2.78M |
| Dividends paid | - | - | - | - |
AYTU BIOPHARMA, INC reported operating cash flow of $3.28M for fiscal year 2026. That is up 269.4% from -$1.94M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from -$13.83M (FY 2017) to $3.28M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$7.90M | $15.44M | -$1.26M | $8.87M | $1.53M | $30.31M |